India to South Africa: Telmisartan Export Trade Route

The India to South Africa Telmisartan corridor is one of India's established pharmaceutical export routes, with 56 shipments documented worth a combined $3.5M USD. The route is dominated by ALEMBIC PHARMACEUTICALS LIMITED, which alone accounts for roughly 73% of all export value, reflecting the consolidated nature of India's telmisartan manufacturing sector.

Across 16 active suppliers, the average shipment value stands at $62.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with telmisartan's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 30.6%, placing it at rank #18 among India's top telmisartan export destinations globally.

On the import side, key buyers of Indian telmisartan in South Africa include RANBAXY PHARMACEUTICALS, PHARMA VISION PTY LTD, UNICORN PHARMACEUTICALS PTY LIMITED and 19 others. RANBAXY PHARMACEUTICALS is the single largest importer with 5 shipments valued at $1.6M USD.

India's telmisartan exports to South Africa are driven primarily by a handful of large-scale manufacturers. ALEMBIC PHARMACEUTICALS LIMITED with 13 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 16 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ALEMBIC PHARMACEUTICALS LIMITED, JUBILANT GENERICS LIMITED, ALEMBIC PHARMACEUTICALS LTD — together account for 84% of total trade value on this route. The average shipment value of $62.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as amtelip(telmisartan and amlodipine)40+5mg 3x10t batch no.2305015869 mfg.dt.oct2023 exp.sep2026 and amtelip(telmisartan and amlodipine)80+10mg 3x10t batch no. 2305016084 mfg.dt.oct2023 exp.sep2026, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, RANBAXY PHARMACEUTICALS is the largest importer with 5 shipments worth $1.6M USD — representing 47% of all telmisartan imports from India on this route. A total of 22 buyers are active on this corridor.